Herein, RR treatment was associated with a significantly higher pooled 3-year OS for treated patients as compared to PA, although the pooled HR for OS throughout the entirety of the follow-up period did not achieve significance when comparing these two therapeutic strategies.
← all excerpts
Repeat resection versus percutaneous ablation for recurrent hepatocellular carcinoma: a meta-analysis.
1
—
—